1. Home
  2. CNXC vs FOLD Comparison

CNXC vs FOLD Comparison

Compare CNXC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNXC
  • FOLD
  • Stock Information
  • Founded
  • CNXC 1991
  • FOLD 2002
  • Country
  • CNXC United States
  • FOLD United States
  • Employees
  • CNXC N/A
  • FOLD N/A
  • Industry
  • CNXC Computer Software: Prepackaged Software
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNXC Technology
  • FOLD Health Care
  • Exchange
  • CNXC Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • CNXC 3.0B
  • FOLD 2.9B
  • IPO Year
  • CNXC N/A
  • FOLD 2007
  • Fundamental
  • Price
  • CNXC $40.48
  • FOLD $9.80
  • Analyst Decision
  • CNXC Buy
  • FOLD Strong Buy
  • Analyst Count
  • CNXC 5
  • FOLD 8
  • Target Price
  • CNXC $79.00
  • FOLD $16.71
  • AVG Volume (30 Days)
  • CNXC 775.2K
  • FOLD 2.8M
  • Earning Date
  • CNXC 01-22-2025
  • FOLD 11-06-2024
  • Dividend Yield
  • CNXC 3.29%
  • FOLD N/A
  • EPS Growth
  • CNXC N/A
  • FOLD N/A
  • EPS
  • CNXC 3.08
  • FOLD N/A
  • Revenue
  • CNXC $9,401,638,000.00
  • FOLD $493,671,000.00
  • Revenue This Year
  • CNXC $37.84
  • FOLD $34.30
  • Revenue Next Year
  • CNXC $1.69
  • FOLD $21.78
  • P/E Ratio
  • CNXC $13.15
  • FOLD N/A
  • Revenue Growth
  • CNXC 44.09
  • FOLD 32.58
  • 52 Week Low
  • CNXC $36.28
  • FOLD $9.02
  • 52 Week High
  • CNXC $106.10
  • FOLD $14.57
  • Technical
  • Relative Strength Index (RSI)
  • CNXC 39.27
  • FOLD 45.87
  • Support Level
  • CNXC $41.65
  • FOLD $9.41
  • Resistance Level
  • CNXC $43.84
  • FOLD $9.99
  • Average True Range (ATR)
  • CNXC 2.12
  • FOLD 0.35
  • MACD
  • CNXC -0.38
  • FOLD 0.03
  • Stochastic Oscillator
  • CNXC 11.50
  • FOLD 48.15

About CNXC Concentrix Corporation

Concentrix Corp is a technology-enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five primary industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Canada, Germany, Great Britain and others.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: